3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes

Thyroid

Volumn 27, Issue 1, 2017, Pages 11-22

  Schanze, Nancy ^a,b   Jacobi, Simon Friedrich ^a,b   Rijntjes, Eddy ^a   Mergler, Stefan ^a   Del Olmo, Marta ^a   Hoefig, Carolin Stephanie ^a,b   Khajavi, Noushafarin ^a   Lehmphul, Ina ^a   Biebermann, Heike ^a   Mittag, Jens ^b,c   Köhrle, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

3 iodothyroacetic acid; 3 iodothyronamine; Nis; thyrocytes; thyroid hormone; thyronamine

Indexed keywords

3 IODOTHYROACETIC ACID; 3 IODOTHYRONAMINE; CALCIUM; DRUG METABOLITE; IODIDE; MESSENGER RNA; THYROID HORMONE; THYRONAMINE; THYROTROPIN; UNCLASSIFIED DRUG; 3-IODOTHYRONAMINE; ANION TRANSPORT PROTEIN; COTRANSPORTER; SLC26A4 PROTEIN, MOUSE; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYRONINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DEIODINASE 1 GENE; DRUG METABOLISM; DRUG UPTAKE; ENDOCRINE FUNCTION; FLUID INTAKE; FOOD INTAKE; GENE; GENE EXPRESSION; GLUCOSE UTILIZATION; HYPOTHALAMIC PITUITARY THYROID AXIS; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PENDRIN GENE; PRIORITY JOURNAL; RAT; RNA ANALYSIS; SODIUM IODIDE SYMPORTER GENE; THYROGLOBULIN GENE; THYROID FOLLICULAR CELL; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE SYNTHESIS; THYROTROPIN SUBUNIT BETA GENE; ANIMAL; C57BL MOUSE; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM;

ANIMALS; ANION TRANSPORT PROTEINS; CELL LINE; GENE EXPRESSION; IODIDES; MALE; MICE; MICE, INBRED C57BL; SYMPORTERS; THYROGLOBULIN; THYROID EPITHELIAL CELLS; THYROID GLAND; THYRONINES;

EID: 85009115826     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2016.0182     Document Type: Article

References (67)

1. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R 1990 Thyroidal and peripheral production of 3,5,3-triiodothyronine in humans by multicompartmental analysis. Am J Physiol 258:E715-726.
2. Larsen PR 1975 Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. J Clin Endocrinol Metab 41:1098-1104.
3. Köhrle J 1999 Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 151:103-119.
4. Gereben B, Zeold A, Dentice M, Salvatore D, Bianco AC 2008 Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol Life Sci 65:570-590.
5. Bernal J 2007 Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 3:249-259.
6. Mullur R, Liu YY, Brent GA 2014 Thyroid hormone regulation of metabolism. Physiol Rev 94:355-382.
7. Schussler GC 2000 The thyroxine-binding proteins. Thyroid 10:141-149.
8. Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X 2006 Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246:121-127.
9. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135.
10. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22:1357-1369.
11. Tohyama K, Kusuhara H, Sugiyama Y 2004 Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 145:4384-4391.
12. Hoefig CS, Wuensch T, Rijntjes E, Lehmphul I, Daniel H, Schweizer U, Mittag J, Köhrle J 2015 Biosynthesis of 3-iodothyronamine from T4 in murine intestinal tissue. Endocrinology 156:4356-4364.
13. Gaddum JH 1927 Quantitative observations on thyroxine and allied substances: I. The use of tadpoles. J Physiol 64:246-254.
14. Hillmann G, Keil B, Taslimi P 1958 Nachweis von Thyroxamin in Thyreoidea und Plasma. Z Naturforschg 13: 820-821.
15. Hillmann G, Keil B 1961 The distribution of I-131-labelled thyroxamine in the body of the rat. Z Gesamte Exp Med 134:380-382.
16. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10: 638-642.
17. Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS, Zucchi R 2010 Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151:5063-5073.
18. Hoefig CS, Köhrle J, Brabant G, Dixit K, Yap B, Strasburger CJ, Wu Z 2011 Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. J Clin Endocrinol Metab 96:1864-1872.
19. Doyle KP, Suchland KL, Ciesielski TM, Lessov NS, Grandy DK, Scanlan TS, Stenzel-Poore MP 2007 Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 38:2569-2576.
20. Braulke LJ, Klingenspor M, DeBarber A, Tobias SC, Grandy DK, Scanlan TS, Heldmaier G 2008 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J Comp Physiol B 178:167-177.
21. Haviland JA, Reiland H, Butz DE, Tonelli M, Porter WP, Zucchi R, Scanlan TS, Chiellini G, Assadi-Porter FM 2013 NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment. Obesity (Silver Spring) 21:2538-2544.
22. Mariotti V, Melissari E, Iofrida C, Righi M, Di Russo M, Donzelli R, Saba A, Frascarelli S, Chiellini G, Zucchi R, Pellegrini S 2014 Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern. PLoS One 9:e106923.
23. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, Grandy DK, Fliers E, Kalsbeek A 2009 Central effects of thyronamines on glucose metabolism in rats. J Endocrinol 201:377-386.
24. Manni ME, De Siena G, Saba A, Marchini M, Dicembrini I, Bigagli E, Cinci L, Lodovici M, Chiellini G, Zucchi R, Raimondi L 2012 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice. Br J Pharmacol 166:650-658.
25. PiehlS,Hoefig CS,ScanlanTS,Köhrle J 2011Thyronamines-past, present, and future. Endocr Rev 32:64-80.
26. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G 1987 One-and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7:3365-3370.
27. Fusco A, Berlingieri MT, Di Fiore PP, Grieco M, Portella G, Santoro M, Vecchio G 1985 Epithelial Transformation by Newly Isolated Murine Retroviruses. From Oncogenes to Tumor Antigens. Elsevier Science Publishers BV, Amsterdam, pp 17-23.
28. Dinter J, Muhlhaus J, Jacobi SF, Wienchol CL, Coster M, Meister J, Hoefig CS, Muller A, Köhrle J, Gruters A, Krude H, Mittag J, Schoneberg T, Kleinau G, Biebermann H 2015 3-iodothyronamine differentially modulates alpha-2Aadrenergic receptor-mediated signaling. J Mol Endocrinol 54:205-216.
29. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J 2007 qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19.
30. Wirth EK, Rijntjes E, Meyer F, Köhrle J, Schweizer U 2015 High T3, low T4 serum levels in Mct8 deficiency are not caused by increased hepatic conversion through type I deiodinase. Eur Thyroid J 4:87-91.
31. Rathmann D, Rijntjes E, Lietzow J, Köhrle J 2015 Quantitative analysis of thyroid hormone metabolites in cell culture samples using LC-MS/MS. Eur Thyroid J 4:51-58.
32. Bradford MM 1976A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
33. Waltz F, Pillette L, Ambroise Y 2010A nonradioactive iodide uptake assay for sodium iodide symporter function. Anal Biochem 396:91-95.
34. Sandell EB, Kolthoff IM 1937 Micro determination of iodine by a catalytic method. Mikrochim Acta 1:9-25.
35. Renko K, Hoefig CS, Hiller F, Schomburg L, Köhrle J 2012 Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay. Endocrinology 153:2506-2513.
36. Nicholls DG, Darley-Usmar VM, Wu M, Jensen PB, Rogers GW, Ferrick DA 2010 Bioenergetic profile experiment using C2C12 myoblast cells. J Vis Exp 2010 Dec 6. DOI: 10. 3791/2511.
37. Wang R, Novick SJ, Mangum JB, Queen K, Ferrick DA, Rogers GW, Stimmel JB 2015 The acute extracellular flux (XF) assay to assess compound effects on mitochondrial function. J Biomol Screen 20:422-429.
38. Khajavi N, Reinach PS, Slavi N, Skrzypski M, Lucius A, Strauss O, Köhrle J, Mergler S 2015 Thyronamine induces TRPM8 channel activation in human conjunctival epithelial cells. Cell Signal 27:315-325.
39. Kleinau G, Pratzka J, Nurnberg D, Gruters A, Fuhrer-Sakel D, Krude H, Köhrle J, Schoneberg T, Biebermann H 2011 Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists. PLoS One 6:e27073.
40. Wood WJ, Geraci T, Nilsen A, DeBarber AE, Scanlan TS 2009 Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo. Chembiochem 10:361-365.
41. Agretti P, De Marco G, Russo L, Saba A, Raffaelli A, Marchini M, Chiellini G, Grasso L, Pinchera A, Vitti P, Scanlan TS, Zucchi R, TonaccheraM2011 3-Iodothyronaminemetabolism and functional effects in FRTL5 thyroid cells. JMol Endocrinol 47:23-32.
42. Ghelardoni S, Chiellini G, Frascarelli S, Saba A, Zucchi R 2014 Uptake and metabolic effects of 3-iodothyronamine in hepatocytes. J Endocrinol 221:101-110.
43. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B, Köhrle J 2008 Thyronamines are isozymespecific substrates of deiodinases. Endocrinology 149: 3037-3045.
44. Dohan O, Carrasco N 2003 Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol 213:59-70.
45. Lucius A, Khajavi N, Reinach PS, Kö hrle J, Dhandapani P, Huimann P, Ljubojevic N, Grotzinger C, Mergler S 2015 3-Iodothyronamine increases transient receptor potential melastatin channel 8 (TRPM8) activity in immortalized human corneal epithelial cells. Cell Signal 28:136-147.
46. Hackenmueller SA, Marchini M, Saba A, Zucchi R, Scanlan TS 2012 Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4. Endocrinology 153:5659-5667.
47. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379: 458-460.
48. Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, Pedersen IB, Carle A 2010 Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 24:13-27.
49. Arvan P, Kim PS, Kuliawat R, Prabakaran D, Muresan Z, Yoo SE, Abu Hossain S 1997 Intracellular protein transport to the thyrocyte plasma membrane: potential implications for thyroid physiology. Thyroid 7:89-105.
50. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, Kohn LD, Green ED 2000 Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141:839-845.
51. Silveira JC, Kopp PA 2015 Pendrin and anoctamin as mediators of apical iodide efflux in thyroid cells. Curr Opin Endocrinol Diabetes Obes 22:374-380.
52. Sheffield VC, Kraiem Z, Beck JC, Nishimura D, Stone EM, Salameh M, Sadeh O, Glaser B 1996 Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification. Nat Genet 12:424-426.
53. Lawrence JE, Lamm SH, Pino S, Richman K, Braverman LE 2000 The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid 10:659-663.
54. Di Cosmo C, Liao XH, Dumitrescu AM, Philp NJ, Weiss RE, Refetoff S 2010 Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. J Clin Invest 120:3377-3388.
55. Roy G, Placzek E, Scanlan TS 2012 ApoB-100-containing lipoproteins are major carriers of 3-iodothyronamine in circulation. J Biol Chem 287:1790-1800.
56. Laurino A, De Siena G, Saba A, Chiellini G, Landucci E, Zucchi R, Raimondi L 2015 In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine. Eur J Pharmacol 761:130-134.
57. Hoefig CS, Jacobi SF, Warner A, Harder L, Schanze N, Vennstrom B, Mittag J 2015 3-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo. Br J Pharmacol 172:3426-3433.
58. Zucchi R, Accorroni A, Chiellini G 2014 Update on 3-iodothyronamine and its neurological and metabolic actions. Front Physiol 5:402.
59. Dumont JE, Rocmans PA 1964 In vivo effects of thyrotropin on the metabolism of the thyroid gland. J Physiol 174:26-45.
60. Laurent E, Mockel J, Van Sande J, Graff I, Dumont JE 1987 Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol 52:273-278.
61. Dumont JE, Willems C, Van Sande J, Neve P 1971 Regulation of the release of thyroid hormones: role of cyclic AMP. Ann N Y Acad Sci 185:291-316.
62. Behrendt HJ, Germann T, Gillen C, Hatt H, Jostock R 2004 Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. Br J Pharmacol 141:737-745.
63. Liu T, Fang Z, Wang G, Shi M, Wang X, Jiang K, Yang Z, Cao R, Tao H, Wang X, Zhou J 2016 Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells. Oncol Lett 11:182-188.
64. Yamanaka MK, Kelly LE 1981A calcium/calmodulindependent cyclic adenosine monophosphate phosphodiesterase from Drosophila heads. Biochim Biophys Acta 674: 277-286.
65. Sharma RK, Das SB, Lakshmikuttyamma A, Selvakumar P, Shrivastav A 2006 Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review. Int J Mol Med 18:95-105.
66. Eggo MC 2010 Molecular regulation of thyroid gland function. Curr Opin Endocrinol Diabetes Obes 17:396-401.
67. Werry TD, Wilkinson GF, Willars GB 2003 Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochem J 374: 281-296.